In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27% in people in the early stages of the disease.
Study: Alzheimer s drug shows modest success slowing declines in memory, thinking wcbe.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcbe.org Daily Mail and Mail on Sunday newspapers.
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.